249 related articles for article (PubMed ID: 23327997)
41. BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.
Strinic D; Belosic Halle Z; Luetic K; Nedic A; Petrovic I; Sucic M; Zivanovic Posilovic G; Balenovic D; Strbe S; Udovicic M; Drmic D; Stupnisek M; Lovric Bencic M; Seiwerth S; Sikiric P
Life Sci; 2017 Oct; 186():66-79. PubMed ID: 28797793
[TBL] [Abstract][Full Text] [Related]
42. In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro.
Lozic M; Stambolija V; Krezic I; Dugandzic A; Zivanovic-Posilovic G; Gojkovic S; Kovacevic J; Vrdoljak L; Mirkovic I; Kokot A; Petrovic A; Pavlov KH; Drmic D; Suran J; Blagaic AB; Seiwerth S; Sikiric P
Emerg Med Int; 2020; 2020():6805354. PubMed ID: 32566305
[TBL] [Abstract][Full Text] [Related]
43. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing.
Sikiric P; Rucman R; Turkovic B; Sever M; Klicek R; Radic B; Drmic D; Stupnisek M; Misic M; Vuletic LB; Pavlov KH; Barisic I; Kokot A; Peklic M; Strbe S; Blagaic AB; Tvrdeic A; Rokotov DS; Vrcic H; Staresinic M; Seiwerth S
Curr Pharm Des; 2018; 24(18):1990-2001. PubMed ID: 29879879
[TBL] [Abstract][Full Text] [Related]
44. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats.
Sikiric P; Seiwerth S; Grabarevic Z; Rucman R; Petek M; Jagic V; Turkovic B; Rotkvic I; Mise S; Zoricic I; Konjevoda P; Perovic D; Simicevic V; Separovic J; Hanzevacki M; Ljubanovic D; Artukovic B; Bratulic M; Tisljar M; Rekic B; Gjurasin M; Miklic P; Buljat G
J Physiol Paris; 1997; 91(3-5):113-22. PubMed ID: 9403784
[TBL] [Abstract][Full Text] [Related]
45. Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats.
Ilic S; Drmic D; Zarkovic K; Kolenc D; Brcic L; Radic B; Djuzel V; Blagaic AB; Romic Z; Dzidic S; Kalogjera L; Seiwerth S; Sikiric P
Eur J Pharmacol; 2011 Sep; 667(1-3):322-9. PubMed ID: 21645505
[TBL] [Abstract][Full Text] [Related]
46. Gastric pentadecapeptide BPC 157 promotes corneal epithelial defects healing in rats.
Lazić R; Gabrić N; Dekaris I; Bosnar D; Boban-Blagaić A; Sikirić P
Coll Antropol; 2005 Jun; 29(1):321-5. PubMed ID: 16117343
[TBL] [Abstract][Full Text] [Related]
47. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat.
Cerovecki T; Bojanic I; Brcic L; Radic B; Vukoja I; Seiwerth S; Sikiric P
J Orthop Res; 2010 Sep; 28(9):1155-61. PubMed ID: 20225319
[TBL] [Abstract][Full Text] [Related]
48. Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability.
Klicek R; Kolenc D; Suran J; Drmic D; Brcic L; Aralica G; Sever M; Holjevac J; Radic B; Turudic T; Kokot A; Patrlj L; Rucman R; Seiwerth S; Sikiric P
J Physiol Pharmacol; 2013 Oct; 64(5):597-612. PubMed ID: 24304574
[TBL] [Abstract][Full Text] [Related]
49. Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test.
Sikiric P; Jelovac N; Jelovac-Gjeldum A; Dodig G; Staresinic M; Anic T; Zoricic I; Ferovic D; Aralica G; Buljat G; Prkacin I; Lovric-Bencic M; Separovic J; Seiwerth S; Rucman R; Petek M; Turkovic B; Ziger T
Acta Pharmacol Sin; 2001 Mar; 22(3):225-30. PubMed ID: 11742568
[TBL] [Abstract][Full Text] [Related]
50. Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, do we have a Solution?
Sikiric P; Seiwerth S; Rucman R; Drmic D; Stupnisek M; Kokot A; Sever M; Zoricic I; Zoricic Z; Batelja L; Ziger T; Luetic K; Vlainic J; Rasic Z; Bencic ML
Curr Pharm Des; 2017; 23(27):4012-4028. PubMed ID: 28228068
[TBL] [Abstract][Full Text] [Related]
51. Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation.
Sever AZ; Sever M; Vidovic T; Lojo N; Kolenc D; Vuletic LB; Drmic D; Kokot A; Zoricic I; Coric M; Vlainic J; Poljak L; Seiwerth S; Sikiric P
Eur J Pharmacol; 2019 Mar; 847():130-142. PubMed ID: 30690000
[TBL] [Abstract][Full Text] [Related]
52. Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect.
Kalogjera L; Krezic I; Smoday IM; Vranes H; Zizek H; Yago H; Oroz K; Vukovic V; Kavelj I; Novosel L; Zubcic S; Barisic I; Beketic Oreskovic L; Strbe S; Sever M; Sjekavica I; Skrtic A; Boban Blagaic A; Seiwerth S; Sikiric P
World J Gastroenterol; 2023 Jul; 29(27):4289-4316. PubMed ID: 37545637
[TBL] [Abstract][Full Text] [Related]
53. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.
Sikirić P; Mikus D; Seiwerth S; Grabarević Z; Rucman R; Petek M; Jagić V; Turković B; Rotkvić I; Mise S; Zoricić I; Perić J; Konjevoda P; Perović D; Jurina L; Hanzevacki M; Separović J; Gjurasin M; Jadrijević S; Jelovac N; Miklić P; Buljat G; Marović A
Dig Dis Sci; 1997 May; 42(5):1029-37. PubMed ID: 9149058
[TBL] [Abstract][Full Text] [Related]
54. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.
Sikiric P; Seiwerth S; Rucman R; Turkovic B; Rokotov DS; Brcic L; Sever M; Klicek R; Radic B; Drmic D; Ilic S; Kolenc D; Vrcic H; Sebecic B
Curr Pharm Des; 2011; 17(16):1612-32. PubMed ID: 21548867
[TBL] [Abstract][Full Text] [Related]
55. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation.
Sebecić B; Nikolić V; Sikirić P; Seiwerth S; Sosa T; Patrlj L; Grabarević Z; Rucman R; Petek M; Konjevoda P; Jadrijević S; Perović D; Slaj M
Bone; 1999 Mar; 24(3):195-202. PubMed ID: 10071911
[TBL] [Abstract][Full Text] [Related]
56. Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury.
Gjurasin M; Miklic P; Zupancic B; Perovic D; Zarkovic K; Brcic L; Kolenc D; Radic B; Seiwerth S; Sikiric P
Regul Pept; 2010 Feb; 160(1-3):33-41. PubMed ID: 19903499
[TBL] [Abstract][Full Text] [Related]
57. A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine.
Sikiric P; Marovic A; Matoz W; Anic T; Buljat G; Mikus D; Stancic-Rokotov D; Separovic J; Seiwerth S; Grabarevic Z; Rucman R; Petek M; Ziger T; Sebecic B; Zoricic I; Turkovic B; Aralica G; Perovic D; Duplancic B; Lovric-Bencic M; Rotkvic I; Mise S; Jagic V; Hahn V
J Physiol Paris; 1999 Dec; 93(6):505-12. PubMed ID: 10672997
[TBL] [Abstract][Full Text] [Related]
58. Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress.
Sikirić P; Mazul B; Seiwerth S; Grabarević Z; Rucman R; Petek M; Jagić V; Turković B; Rotkvić I; Mise S; Zoricić I; Jurina L; Konjevoda P; Hanzevacki M; Gjurasin M; Separović J; Ljubanović D; Artuković B; Bratulić M; Tisljar M; Miklić P; Sumajstorcić J
Dig Dis Sci; 1997 Mar; 42(3):661-71. PubMed ID: 9073154
[TBL] [Abstract][Full Text] [Related]
59. Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats.
Mirković I; Kralj T; Lozić M; Stambolija V; Kovačević J; Vrdoljak L; Zlatar M; Milanović K; Drmić D; Predović J; Masnec S; Jurjević M; Bušić M; Seiwerth S; Kokot A; Sikirić P
Acta Clin Croat; 2020 Sep; 59(3):394-406. PubMed ID: 34177048
[TBL] [Abstract][Full Text] [Related]
60. Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.
Belosic Halle Z; Vlainic J; Drmic D; Strinic D; Luetic K; Sucic M; Medvidovic-Grubisic M; Pavelic Turudic T; Petrovic I; Seiwerth S; Sikiric P
Inflammopharmacology; 2017 May; ():. PubMed ID: 28516373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
